Background/Objectives: A sub-anesthetic dose of ketamine has shown promise in reducing craving, withdrawal symptoms, and use of drugs such as alcohol, cocaine, and opioids among individuals with substance use disorders. Ketamine’s therapeutic potential for tobacco use is unknown. Here, we investigated a single sub-anesthetic dose among adults with tobacco use disorder who were not interested in...
There is increasing evidence of ketamine's therapeutic potential in reducing substance use in individuals with substance use disorders. However, its effects on tobacco use disorder are unknown. We investigated the effect of a subanesthetic dose of ketamine on tobacco use. This randomized, single-blind, placebo-controlled, pilot study administered intravenous ketamine to individuals with tobacco...
AbstractBackgroundNo therapy has shown robust efficacy for treating psychostimulant dependence. Meanwhile, the feasibility and effectiveness of direct spiritual healing modalities for this disorder are unknown.ObjectivesTo determine the acceptability of participating in research using a spiritual healing approach, namely shamanic healing, among psychostimulant users.MethodsPsychostimulant users...